For the past 20 years, many of the dramatic improvements in cancer outcomes can be attributed to personalized cancer ...

Dipika Kakar, in a recent video gives more insight on her progress with the deadly medical condition. She talks about side ...

A parolee, Chandan Mishra, facing murder charges, was attacked by a rival gang at a Patna hospital while receiving treatment.

Zenith Epigenetics' ZEN-3694 gains FDA fast track designation, offering hope for patients with aggressive NUT carcinoma ...

The response rate to Amtagvi was higher in patients who had received two or fewer therapies than in those with more heavily ...

Iovance Biotherapeutics’ Amtagvi study data shows 49 per cent response rate for commercialisation: San Carlos, California Thursday, July 17, 2025, 12:00 Hrs [IST] Iovance Biothe ...

Carotuximab plus Erleada proved safe in the first 10 patients with metastatic castration-resistant prostate cancer dosed on ...

Dr. Olalekan O. Oluwole explained how CAR T is used to treat high-risk blood cancers and highlighted the potential of ...

Analysis of diagnostics and treatments, revenue projections (2025-2030), and segmentation by disease type, product type, and region. Discover trends, challenges, competitive landscape, ESG ...

From dissecting clinical updates to identifying novel targets beyond NLRP3, this summit brings together the brightest minds transforming the field of innate immunity and inflammation.

The department of oncopathology at the hospital will now use NGS technology to analyse genetic mutations in cancer patients, ...

The technology is a form of targeted radiotherapy that uses a boron-containing drug. AXA China Region Insurance Company (Bermuda) Limited and AXA International Reinsurance (Shanghai) Company Limited ...